147 related articles for article (PubMed ID: 32624192)
1. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
Guzman-Prado Y
Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
[No Abstract] [Full Text] [Related]
2. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
Jeevaratnam K
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
[No Abstract] [Full Text] [Related]
3. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
Sahraei Z; Shabani M; Shokouhi S; Saffaei A
Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
[No Abstract] [Full Text] [Related]
4. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
Guastalegname M; Vallone A
Clin Infect Dis; 2020 Jul; 71(15):888-889. PubMed ID: 32211771
[No Abstract] [Full Text] [Related]
5. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC
Asia Pac J Ophthalmol (Phila); 2020; 9(4):375-376. PubMed ID: 32740072
[No Abstract] [Full Text] [Related]
6. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
Gao J; Hu S
Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
[TBL] [Abstract][Full Text] [Related]
7. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.
Wiwanitkit V
Asia Pac J Ophthalmol (Phila); 2020; 9(4):374. PubMed ID: 32740070
[No Abstract] [Full Text] [Related]
8. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
D'Acquarica I; Agranat I
Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
[No Abstract] [Full Text] [Related]
9. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
[No Abstract] [Full Text] [Related]
10. Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
Ann Intern Med; 2020 Aug; 173(4):W78-W79. PubMed ID: 32667853
[No Abstract] [Full Text] [Related]
11. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
Frishman WH
Cardiol Rev; 2020; 28(5):217-218. PubMed ID: 32639241
[No Abstract] [Full Text] [Related]
12. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
Piszczatoski CR; Powell J
Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
[No Abstract] [Full Text] [Related]
14. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
[No Abstract] [Full Text] [Related]
15. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
Allam MF; Andraous F
Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
[No Abstract] [Full Text] [Related]
16. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
Decloedt EH; Reuter H; Allwood B; Parker A; Koegelenberg CFN; Blockman M; Taljaard J
S Afr Med J; 2020 Apr; 110(5):12903. PubMed ID: 32657706
[No Abstract] [Full Text] [Related]
17. COVID-19 and hydroxychloroquine: Let the available data speak for themselves.
Paliani U; Cardona A
Eur J Intern Med; 2020 Oct; 80():121. PubMed ID: 32709544
[No Abstract] [Full Text] [Related]
18. Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.
Principi N; Esposito S
Lancet Infect Dis; 2020 Oct; 20(10):1118. PubMed ID: 32311322
[No Abstract] [Full Text] [Related]
19. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
[TBL] [Abstract][Full Text] [Related]
20. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
Lebin JA; LeSaint KT
West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
